POS0670 ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3) IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH LONG-TERM UPADACITINIB THERAPY

Background: Routine Assessment of Patient Index Data 3 (RAPID3) is a pooled index of 3 patient-reported measures: patient global assessment, pain, and physical function. RAPID3 was shown to correlate with other composite measures of disease activity 1 and is recommended by the American College of Rheumatology for use in clinical practice. 2 Objectives: To evaluate the impact of upadacitinib (UPA) versus comparators on RAPID3 over 60 weeks, as...